FDA Approved: BETAXOLOL — Supplemental Application (Epic Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application (ANDA075541) for Betaxolol from Epic Pharma LLC, marking an approved change under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Betaxolol (Betaxolol)

Snippet

SUPPL AP for BETAXOLOL (BETAXOLOL)